TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/23 07:05 | 8/17/23 | VIRI | Virios Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Gregory Scott | GA | DO | CEO | P | 31 | 1.25 | 0 | 25 | 77 | 57 | D | ||||||||||||||
5/24/22 10:24 | 5/23/22 | VIRI | Virios Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Gregory Scott | GA | DO | CEO | P | 34 | 4.52 | 0 | 8 | 30 | 32 | D | ||||||||||||||
12/22/21 13:23 | 12/21/21 | VIRI | Virios Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Gregory Scott | GA | DO | CEO | P | 28 | 5.52 | 0 | 5 | 25 | 25 | D | ||||||||||||||
4/7/21 13:59 | 4/6/21 | VIRI | Virios Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Gregory Scott | GA | DO | CEO | P | 2 | 6.36 | 0 | 0 | 2 | 20 | D | ||||||||||||||
4/6/21 21:56 | 4/5/21 | VIRI | Virios Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Gregory Scott | GA | DO | CEO | P.a | 97 | 6.17 | 0 | 16 | 402 | 20 | D | ||||||||||||||
4/6/21 15:38 | 4/5/21 | VIRI | Virios Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Duncan Gregory Scott | GA | DO | CEO | P | 97 | 6.17 | 0 | 16 | 402 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |